Clinical Trial Update: Soy Protein Supplement in Preventing Prostate Cancer in Patients With Elevated Prostate-Specific Antigen Levels [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a soy protein supplement to prevent prostate cancer in men with elevated PSA levels has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Soy Protein Supplement

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED